InMode Ltd. (INMD) is a Medical - Devices company in the Healthcare sector, currently trading at $14.14. It has a SharesGrow Score of 68/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of INMD = $24.89 (+76% from the current price, the stock appears undervalued). Analyst consensus target is INMD = $16 (+13.2% upside).
Valuation: INMD trades at a trailing Price-to-Earnings (P/E) of 9.3 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.56.
Financials: revenue is $370M, -5.9%/yr average growth. Net income is $94M, growing at -11.4%/yr. Net profit margin is 25.3% (strong). Gross margin is 78.5% (-5.3 pp trend).
Balance sheet: total debt is $13M against $683M equity (Debt-to-Equity (D/E) ratio 0.02, conservative). Current ratio is 9.88 (strong liquidity). Debt-to-assets is 1.7%. Total assets: $766M.
Analyst outlook: 6 / 11 analysts rate INMD as buy (55%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 74/100 (Pass), Growth 15/100 (Fail), Past 100/100 (Pass), Health 100/100 (Pass), Moat 49/100 (Partial), Future 52/100 (Partial), Income 85/100 (Pass).
